When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
MIDAS Healthcare Solutions, Inc., the leading developer of technology-driven solutions to promote the safe use, storage, return, and disposal of controlled substances and other dangerous medications in hospitals and other healthcare institutions, announced today…
Continue Reading
The DEA has extended remote prescribing of controlled substances until the end of 2024, granting a second extension to consider new regulations. This move eliminates the proposed rule requiring in-person visits for controlled medication…
Continue Reading
At the Drug Enforcement Agency Drug Diversion Division listening sessions earlier this month, DEA Administrator Anne Milgram said the agency would hold a second comment period on its March NPRM in the months ahead.WHY…
Continue Reading
To ensure compliance with Electronic Prescribing of Controlled Substances (EPCS), healthcare providers can turn to IdenTrust’s one-stop solution for streamlined identity-proofing and multi-factor authentication. With the rise of e-prescribing legislation and the opioid crisis,…
Continue Reading
Welcome to the exciting world of digital health startups! In this video, we’ll walk you through the key regulations you need to know to thrive in this fast-paced industry without getting bogged down in…
Continue Reading
This is a developing story with updates expected.U.S. Senators Mark Warner (D-Va.), John Thune (R-S.D.) and four of their colleagues expressed support for the Drug Enforcement Administration’s new engagement on a potential special registration…
Continue Reading
As the Drug Enforcement Administration (DEA) holds listening sessions this week for its proposed rule that rolls back Covid-19 flexibilities for the virtual prescribing of controlled substances, four mental health companies issued a letter…
Continue Reading
The DEA’s potential introduction of a telehealth-controlled substance registry is lauded by the American Telemedicine Association (ATA). The DEA’s upcoming listening sessions aim to explore the feasibility of remote prescribing of essential controlled substances…
Continue Reading
The American Telemedicine Association released a statement on Friday saying that it applauds the Drug Enforcement Agency for posting a meeting notice on Friday that indicates that it is “openly considering” a special registration that would…
Continue Reading
